Home
Who We Are
What We Do
Corporate Responsibility
News
Careers
Investors
Patients and HCPS
Contact us
Careers | Investors | Patients and HCPS | Contact us
Careers Investors Patients and HCPS Contact us
Products
Products

Currently, we have five recombinant insulin analogs commercialized in China including long-acting glargine injection (Basalin®), fast-acting lispro injection (Prandilin™), fast-acting aspart injection (Rapilin®), mixed protamine zinc lispro injection (25R) (Prandilin™25), aspart 30 injection (Rapilin®30), and one human insulin injection approved in China - mixed protamine human insulin injection (30R) (Similin®30). We have two medical devices, namely reusable insulin injection pen (GanleePen), and disposable pen needle (GanleeFine®).

*The following products can only be prescribed and purchased in China, for products commercialized outside of China, please contact us (info@ganlee.com) for more information.
Copyright © 2021 Gan & Lee Pharmaceuticals Co Ltd . All Rights Reserved.
Our websites

Subscribe

I read, agree with and accept all of the Privacy Policy and Terms of Use of this website.